BioCentury
ARTICLE | Clinical News

Attenuon preclinical data

April 5, 2004 7:00 AM UTC

In a mouse model of breast cancer, tumors in animals treated with ATN-161 regressed or grew significantly more slowly than tumors in control animals. ATN-161 significantly decreased the number of tumo...